Patents by Inventor Karthigeyan Nanjan

Karthigeyan Nanjan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Injectable antibiotic formulations and their methods of use
    Patent number: 10376585
    Abstract: This invention relates to a composition, including penethamate (PNT) or a pharmaceutical equivalent thereof; and at least one oily vehicle.
    Type: Grant
    Filed: July 16, 2013
    Date of Patent: August 13, 2019
    Assignee: BAYER NEW ZEALAND LTD
    Inventors: Fadil Al Alawi, Olaf Bork, Rohit Jain, Karthigeyan Nanjan, Ian George Tucker
  • Long acting compositions
    Patent number: 9616044
    Abstract: The present invention relates to a long-acting composition for the treatment of an animal in need thereof wherein the composition includes a therapeutically effective amount of a bioactive agent, characterized in that the composition includes a non-aqueous carrier and a solvent system comprising castor oil and at least one cyclic amide.
    Type: Grant
    Filed: March 13, 2013
    Date of Patent: April 11, 2017
    Inventors: Fadil Al Alawi, Karthigeyan Nanjan
  • Injectable antibiotic formulations and their methods of use
    Patent number: 9452155
    Abstract: This invention relates to a composition, including penethamate (PNT) or a pharmaceutical equivalent thereof; and triacetin.
    Type: Grant
    Filed: July 16, 2013
    Date of Patent: September 27, 2016
    Assignee: BAYER NEW ZEALAND LTD
    Inventors: Fadil Al Alawi, Karthigeyan Nanjan
  • Anti-parasitic composition comprising a macrocyclic lactone and levamisole and method of treatment of parasitic infestation
    Patent number: 9198430
    Abstract: This invention relates to a veterinary antiparasitic solubilized composition including a macrocyclic lactone or a pharmaceutically equivalent salt thereof, and levamisole or a pharmaceutically equivalent salt thereof, characterized in that the pH of the composition is in the range of 2.0 to 5.0 and wherein the composition includes at least one surfactant and at least one antioxidant.
    Type: Grant
    Filed: June 22, 2012
    Date of Patent: December 1, 2015
    Assignee: BAYER NEW ZEALAND LIMITED
    Inventors: Wayne Frederick Leech, Fadil Al Alawi, Karthigeyan Nanjan
  • INJECTABLE ANTIBIOTIC FORMULATIONS AND THEIR METHODS OF USE
    Publication number: 20150174248
    Abstract: This invention relates to a composition, including penethamate (PNT) or a pharmaceutical equivalent thereof; and at least one oily vehicle.
    Type: Application
    Filed: July 16, 2013
    Publication date: June 25, 2015
    Inventors: Fadil Al Alawi, Olaf Bork, Rohit Jain, Karthigeyan Nanjan, Ian George Tucker
  • INJECTABLE ANTIBIOTIC FORMULATIONS AND THEIR METHODS OF USE
    Publication number: 20150150854
    Abstract: This invention relates to a composition, including penethamate (PNT) or a pharmaceutical equivalent thereof; and triacetin.
    Type: Application
    Filed: July 16, 2013
    Publication date: June 4, 2015
    Inventors: Fadil Al Alawi, Karthigeyan Nanjan
  • LONG ACTING COMPOSITIONS
    Publication number: 20150038565
    Abstract: The present invention relates to a long-acting composition for the treatment of an animal in need thereof wherein the composition includes a therapeutically effective amount of a bioactive agent, characterised in that the composition includes a non-aqueous carrier and a solvent system comprising castor oil and at least one cyclic amide.
    Type: Application
    Filed: March 13, 2013
    Publication date: February 5, 2015
    Inventors: Fadil Al Alawi, Karthigeyan Nanjan
  • Macrocyclic lactone tablet formulation
    Patent number: 8835397
    Abstract: The invention relates to a table formulated for administration to an animal to treat parasite infestation. The tablet includes at least one macrocyclic lactone compound with anthelmintic activity dissolved in at least one organic solvent and subsequently formulated into a tablet. The tablets produced have a high degree of stability when stored over time and also provide the animal with a dose of agent sufficient to be therapeutically effective.
    Type: Grant
    Filed: December 18, 2007
    Date of Patent: September 16, 2014
    Assignee: Bayer New Zealand Ltd.
    Inventors: Karthigeyan Nanjan, Fadil Al Alawi, Wayne Frederick Leech, Man Yik Li, Steve Li
  • ANTI-PARASITIC COMPOSITION COMPRISING A MACROCYCLIC LACTONE AND LEVAMISOLE AND METHOD OF TREATMENT OF PARASITIC INFESTATION
    Publication number: 20140221299
    Abstract: This invention relates to a veterinary antiparasitic solubilised composition including a macrocyclic lactone or a pharmaceutically equivalent salt thereof, and levamisole or a pharmaceutically equivalent salt thereof, characterised in that the pH of the composition is in the range of 2.0 to 5.0 and wherein the composition includes at least one surfactant and at least one antioxidant.
    Type: Application
    Filed: June 22, 2012
    Publication date: August 7, 2014
    Applicant: BAYER NEW ZEALAND LIMITED
    Inventors: Wayne Frederick Leech, Fadil Al Alawi, Karthigeyan Nanjan
  • Topical formulation
    Patent number: 8748467
    Abstract: The invention relates to composition and related therapeutic methods including at least one antihyperthyroid drug formulated for transdermal administration. Because the formulation is formulated for transdermal administration, the formulation is easier to administer than existing formulations which are administered orally to animals. Issues surrounding transdermal administration versus oral administration have also been resolved allowing the agent to remain stable during storage and retain a high level of efficacy.
    Type: Grant
    Filed: January 22, 2008
    Date of Patent: June 10, 2014
    Assignee: Bayer Intellectual Property GmbH
    Inventors: Karthigeyan Nanjan, Fadil Al Alawi, Paul Chambers, Kate Hill
  • TOPICAL FORMULATION
    Publication number: 20100137389
    Abstract: The invention relates to composition and related therapeutic methods including at least one antihyperthyroid drug formulated for transdermal administration. Because the formulation is formulated for transdermal administration, the formulation is easier to administer than existing formulations which are administered orally to animals. Issues surrounding transdermal administration versus oral administration have also been resolved allowing the agent to remain stable during storage and retain a high level of efficacy.
    Type: Application
    Filed: January 22, 2008
    Publication date: June 3, 2010
    Applicant: BOMAC RESEARCH LIMITED
    Inventors: Karthigeyan Nanjan, Fadil Al Alawi, Paul Chambers, Kate Hill
  • TABLET FORMULATION
    Publication number: 20100016248
    Abstract: The invention relates to a tablet formulated for administration to an animal to treat parasite infestation. The tablet includes at least one macrocyclic lactone compound with anthelmintic activity dissolved in at least one organic solvent and subsequently formulated into a tablet. The tablets produced have a high degree of stability when stored over time and also provide the animal with a dose of agent sufficient to be therapeutically effective.
    Type: Application
    Filed: December 18, 2007
    Publication date: January 21, 2010
    Applicant: BOMAC RESEARCH LIMITED
    Inventors: Karthigeyan Nanjan, Fadil Al Alawi, Wayne Frederick Leech, Man Yik Li, Steve Li